Study Background
Laryngeal carcinoma, a malignancy arising from the larynx, has traditionally been more prevalent among males, with risk factors including tobacco and alcohol use. However, recent epidemiological trends indicate an increasing incidence of laryngeal cancer among female patients. Female-specific clinical characteristics and treatment response patterns may vary due to biological, hormonal, and behavioral factors. Despite this emerging public health concern, literature focusing exclusively on female laryngeal carcinoma patients remains limited. Understanding these characteristics and optimal treatment modalities is crucial to improving patient outcomes and tailoring therapeutic strategies.